$DMRA Cashflow Statement | Understand Stock

$DMRA

$21.96 +$0.70 (3.29%) Close

$DMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation of equipment
Gain on sale of equipment
Stock-based compensation
Issuance of common stock in connection with vesting of restricted stock units
Issuance of preferred and common stock in connection with an Asset Purchase Agreement
In-process research and development costs in connection with Damora Asset Acquisition
Issuance of Paramora Warrant, net of cost assumed in Damora Asset Acquisition
Amortization of premiums and discounts on marketable securities
Net loss on sale of marketable securities
Amortization of right of use lease asset
Accretion of lease liability

Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other assets, noncurrent
Accounts payable
Accrued expenses and other current liabilities
Related party accounts payable and other current liabilities
Operating lease liabilities
Other liabilities, noncurrent
Net cash used in operating activities
Cash flows from investing activities
Purchases of marketable securities
Damora Asset Acquisition costs, net of cash assumed
Proceeds from sale of marketable securities
Proceeds from the sale of equipment
Purchases of property and equipment
Net cash (used in) provided by investing activities

Cash flows from financing activities
Proceeds from issuance of preferred stock in connection with private placement, net of issuance costs
Proceeds from issuance of common stock in connection with stock option exercise
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosures of cash flow information:
Cash paid for taxes
Supplemental disclosures of noncash activities:
Fair value of the Series B Preferred Stock issued in connection with the Damora Asset Acquisition
Operating lease liability arising from obtaining right-of-use assets

Comments